NCT04657211View on ClinicalTrials.gov

Triple Therapy in Chronic Obstructive Pulmonary Disease (COPD) Participants

CompletedOBSERVATIONAL
Enrollment

1,212

Participants

Timeline

Start Date

January 14, 2021

Primary Completion Date

July 1, 2024

Study Completion Date

July 1, 2024

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
OTHER

Prospective observational cohort study

prospective observational cohort study

Trial Locations (1)

30625

GSK Investigational Site, Hanover

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT04657211 - Triple Therapy in Chronic Obstructive Pulmonary Disease (COPD) Participants | Biotech Hunter | Biotech Hunter